TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35067080

Group type: EXPERIMENTAL
Intervention: LIA + continuous postoperative infusion of local anaesthetic for 48 hours
Number of subjects: 108

Group type: COMPARATOR
Intervention: LIA only (Control Group)
Number of subjects: 108
Study: 34031337

Group type: EXPERIMENTAL
Intervention: Pedometer group (PG) - minimum target: 8,000 steps/day; n=36
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (CG) - no change in walking; n=34
Number of subjects: 70
Study: 32370767

Group type: EXPERIMENTAL
Intervention: Alpha/delta neurofeedback training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beta/theta neurofeedback training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diary control group
Number of subjects: 0
Study: 34854157

Group type: EXPERIMENTAL
Intervention: Ion-exchange water softener installed in home
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (usual domestic hard water)
Number of subjects: 80
Study: 34616559

Group type: EXPERIMENTAL
Intervention: Sodium Bicarbonate
Number of subjects: 118

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 118
Study: 35472097

Group type: EXPERIMENTAL
Intervention: Energy-dense enteral nutrition (1.5 kcal/mL)
Number of subjects: 3876

Group type: COMPARATOR
Intervention: Standard enteral nutrition (1.0 kcal/mL)
Number of subjects: 3876

Group type: EXPERIMENTAL
Intervention: Patients with GRV ≥250 mL
Number of subjects: 3876
Study: 33165151

Group type: EXPERIMENTAL
Intervention: repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: rTMS followed by amantadine (rTMS+AMA)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: amantadine (AMA)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: rTMS+AMA
Number of subjects: 4
Study: 34978021

Group type: EXPERIMENTAL
Intervention: Tapered group (n = 17) - Epoprostenol was resumed after reperfusion and gradually tapered over 2 weeks.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Discontinued group (n = 6) - Epoprostenol was discontinued after the establishment of extracorporeal circulation.
Number of subjects: 23
Study: 32138689

Group type: EXPERIMENTAL
Intervention: CKD stage 4
Number of subjects: 5796

Group type: COMPARATOR
Intervention: CKD stage 1-2
Number of subjects: 5796
Study: 32917418

Group type: EXPERIMENTAL
Intervention: Increased intramuscular adipose tissue of the quadriceps
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Quadriceps echo intensity
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Food Intake Level Scale (FILS)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Geriatric Nutritional Risk Index (GNRI) score
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Updated Charlson comorbidity index (UCCI)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Subcutaneous fat thickness of the thigh
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Length of hospital stay
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Quadriceps thickness
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) concentration
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Number of medications
Number of subjects: 371
Study: 32068839

Group type: EXPERIMENTAL
Intervention: iDISK knowledge base
Number of subjects: 50
Study: 36544075

Group type: EXPERIMENTAL
Intervention: One dose of RBX2660 + one dose of placebo
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Two doses of RBX2660
Number of subjects: 134

Group type: COMPARATOR
Intervention: Two doses of placebo
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: One dose of RBX2660 + one dose of placebo (per-protocol population)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Two doses of placebo (per-protocol population)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Two doses of RBX2660 (per-protocol population)
Number of subjects: 134
Study: 34488363

Group type: EXPERIMENTAL
Intervention: Meticulous nursing model
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventional nursing
Number of subjects: 108
Study: 32871704

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) treatment for 8 weeks (n = 18)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) for 4 weeks followed by OLP for 4 weeks (n = 20)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Overall group comparison
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Non-geriatric patients (<65 years) with early onset depression (<50 years)
Number of subjects: 38
Study: 36166095

Group type: EXPERIMENTAL
Intervention: Electromagnetically (EM) navigated TKA
Number of subjects: 199

Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 199
Study: 32579152

Group type: EXPERIMENTAL
Intervention: Genetic knowledge
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Current communication of CRC risk
Number of subjects: 189
Study: 32634485

Group type: EXPERIMENTAL
Intervention: Resilient Youth with NF (RY-NF)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Health Education for NF (HE-NF)
Number of subjects: 200
Study: 35109905

Group type: EXPERIMENTAL
Intervention: ALPS-PHP plate with pegs
Number of subjects: 110

Group type: COMPARATOR
Intervention: PHILOS plate with screws
Number of subjects: 110
Study: 34132703

Group type: EXPERIMENTAL
Intervention: Postoperative monotherapy with PT
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard 2-drug therapy with CM
Number of subjects: 162
Study: 32557923

Group type: EXPERIMENTAL
Intervention: Adenosine dosage of 175 μg/kg/min
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Adenosine dosage of 210 μg/kg/min
Number of subjects: 100

Group type: COMPARATOR
Intervention: Adenosine dosage of 140 μg/kg/min
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison of groups 2 and 3 vs group 1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Group 3 (210 μg/kg/min)
Number of subjects: 100
Study: 35729713

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 30 mg plus MTX
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 80 mg plus MTX
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo plus MTX
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 30 mg
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 80 mg
Number of subjects: 381
Study: 34533430

Group type: EXPERIMENTAL
Intervention: ACHIEVE hearing intervention
Number of subjects: 0
Study: 33766818

Group type: EXPERIMENTAL
Intervention: Doxorubicin with upfront dexrazoxane
Number of subjects: 33

Group type: COMPARATOR
Intervention: Doxorubicin alone (historical control)
Number of subjects: 33
Study: 35973803

Group type: EXPERIMENTAL
Intervention: 1.5 million IU/day of subcutaneous IL-2 (ILT-101) for 5 days followed by weekly injections for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 1.5 million IU/day of subcutaneous IL-2 (ILT-101)
Number of subjects: 100
Study: 33356028

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 950

Group type: COMPARATOR
Intervention: Calcineurin inhibitor (CNI)
Number of subjects: 950
Study: 32310288

Group type: EXPERIMENTAL
Intervention: Mammography Screening Decision Aid (DA)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Control arm (Home Safety pamphlet)
Number of subjects: 546
Study: 35120174

Group type: EXPERIMENTAL
Intervention: MedicineWise app + usual care
Number of subjects: 55

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 55
Study: 34327879

Group type: EXPERIMENTAL
Intervention: NT‐proBNP measurements in newborns with CHD
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: NT‐proBNP measurements in newborns with combined heart defects
Number of subjects: 126
Study: 36163838

Group type: EXPERIMENTAL
Intervention: Enasidenib 100 mg/day
Number of subjects: 319

Group type: COMPARATOR
Intervention: Conventional Care Regimens (CCR)
Number of subjects: 319
Study: 33289297

Group type: EXPERIMENTAL
Intervention: Sotagliflozin 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sotagliflozin 400 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32379288

Group type: EXPERIMENTAL
Intervention: Facedown positioning for 8 hours daily for 5 days
Number of subjects: 185

Group type: COMPARATOR
Intervention: Face forward positioning for 8 hours daily for 5 days
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Facedown positioning
Number of subjects: 185

Group type: COMPARATOR
Intervention: Face forward positioning
Number of subjects: 185
Study: 34915982

Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 36401234

Group type: COMPARATOR
Intervention: Daily calcium citrate 600 mg (control group)
Number of subjects: 34
Study: 33402404

Group type: EXPERIMENTAL
Intervention: Burnaid hydrogel dressing
Number of subjects: 72

Group type: COMPARATOR
Intervention: Plasticised polyvinylchloride film (Control)
Number of subjects: 72
Study: 33941193

Group type: EXPERIMENTAL
Intervention: Self-rated health after reporting bodyweight (treatment group)
Number of subjects: 2523

Group type: COMPARATOR
Intervention: Self-rated health before reporting bodyweight (control group)
Number of subjects: 2523
Study: 32996693

Group type: EXPERIMENTAL
Intervention: Data-driven machine-learning model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simple hypoglycaemia risk score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both models
Number of subjects: 0
Study: 33990478

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump preoperatively in high-risk patients awaiting coronary artery bypass grafting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Impella as part of an early MCS strategy in CS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ECMO facilitated resuscitation
Number of subjects: 0
Study: 32008789

Group type: EXPERIMENTAL
Intervention: Total space available per cow
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Living space per cow
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Farmer opinions on loafing space
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Linear model predicting living space
Number of subjects: 53
Study: 35609139

Group type: EXPERIMENTAL
Intervention: Hematic antegrade repriming (HAR)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 115
Study: 34262557

Group type: EXPERIMENTAL
Intervention: Vitamin D (400 IU daily)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 34269705

Group type: EXPERIMENTAL
Intervention: Motivational intervention based on the 5 R's model delivered by specialized inflammatory bowel disease nurses every 3 months over a 1‐year period
Number of subjects: 144

Group type: COMPARATOR
Intervention: Regular follow-up (Control)
Number of subjects: 144
Study: 32008784

Group type: EXPERIMENTAL
Intervention: Bale cutting engagement (cut)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Orchardgrass
Number of subjects: 24
Study: 35674120

Group type: EXPERIMENTAL
Intervention: Instrument-assisted soft tissue mobilization (IASTM)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Pressure algometry
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham ultrasound (control group)
Number of subjects: 72
Study: 33518708

Group type: EXPERIMENTAL
Intervention: Serotonin depletion (tryptophan depletion)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 73
Study: 37344086

Group type: EXPERIMENTAL
Intervention: Quercetin (500 mg/day)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 33879453

Group type: EXPERIMENTAL
Intervention: Total testosterone levels (observational analysis)
Number of subjects: 333530

Group type: EXPERIMENTAL
Intervention: Sex hormone-binding globulin (SHBG) levels (observational analysis)
Number of subjects: 333530

Group type: EXPERIMENTAL
Intervention: Testosterone levels (Mendelian randomization analysis)
Number of subjects: 333530

Group type: EXPERIMENTAL
Intervention: Free testosterone levels (observational and MR analyses)
Number of subjects: 333530
Study: 35842106

Group type: EXPERIMENTAL
Intervention: Multifaceted clinical pharmacy intervention (medication reconciliation at admission and discharge, medication review, patient/caregiver education, intensified communication with primary care providers, post-discharge follow-up including telepharmacology service)
Number of subjects: 828

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 828

Group type: EXPERIMENTAL
Intervention: Multifaceted clinical pharmacy intervention
Number of subjects: 828
Study: 33475710

Group type: EXPERIMENTAL
Intervention: Regular use of aspirin
Number of subjects: 94540

Group type: EXPERIMENTAL
Intervention: Regular use of aspirin initiated before age 70 years
Number of subjects: 94540

Group type: EXPERIMENTAL
Intervention: Regular use of aspirin initiated at or after age 70 years
Number of subjects: 94540
Study: 32291508

Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) fluorescence angiography
Number of subjects: 131

Group type: COMPARATOR
Intervention: Non-ICG group
Number of subjects: 131
Study: 32896447

Group type: COMPARATOR
Intervention: Normal glycaemic control (NGC)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Impaired glycaemic control (IGC)
Number of subjects: 160
Study: 33273351

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Simple bupivacaine
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 164
Study: 34108079

Group type: COMPARATOR
Intervention: LX9211 (single ascending dose)
Number of subjects: 146

Group type: COMPARATOR
Intervention: LX9211 (multiple ascending dose)
Number of subjects: 146

Group type: COMPARATOR
Intervention: LX9211 (200 mg cohort)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 32954715

Group type: EXPERIMENTAL
Intervention: Noninvasive respiratory volume monitor (RVM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 50
Study: 36084153

Group type: EXPERIMENTAL
Intervention: Intralesional sodium stibogluconate (SSG), administered weekly for a maximum of six doses.
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Intralesional sodium stibogluconate (SSG)
Number of subjects: 83
Study: 33350325

Group type: EXPERIMENTAL
Intervention: Mebeverine 135 mg 3 times a day for 3 months
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo 3 times a day for 3 months
Number of subjects: 99
Study: 35101099

Group type: EXPERIMENTAL
Intervention: Shorter induction schedule of prednisolone (3 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard induction schedule of prednisolone (5 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Substituting doxorubicin with mitoxantrone in delayed intensification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard doxorubicin in delayed intensification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall event-free survival
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Event-free survival by risk groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sepsis rates in induction phase
Number of subjects: 0
Study: 34019470

Group type: EXPERIMENTAL
Intervention: Telephone-based intervention group (T group)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Written notification intervention group (W group)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 800
Study: 33090616

Group type: EXPERIMENTAL
Intervention: Genetic Counselors (GCs)
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Active recommendations (comprehensive, check back, wrong)
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Wrong recommendation
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Correct active recommendations
Number of subjects: 652
Study: 33712356

Group type: EXPERIMENTAL
Intervention: Valsalva maneuver
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 110
Study: 34582720

Group type: EXPERIMENTAL
Intervention: 125 mg NEEM
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 250 mg NEEM
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 500 mg NEEM
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 33827081

Group type: EXPERIMENTAL
Intervention: Nasal High-Frequency Oscillatory Ventilation (NHFOV)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Nasal Continuous Airway Pressure (NCPAP)
Number of subjects: 302
Study: 36424012

Group type: EXPERIMENTAL
Intervention: Conduction System Pacing (CSP)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Biventricular Pacing (BiVP)
Number of subjects: 70
Study: 33597287

Group type: EXPERIMENTAL
Intervention: Bullying perpetration
Number of subjects: 28477

Group type: COMPARATOR
Intervention: Combined bullying-victimization
Number of subjects: 28477
Study: 32602592

Group type: EXPERIMENTAL
Intervention: Cognitive Evolutionary Therapy (CET)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Cognitive Therapy (CT)
Number of subjects: 97
Study: 34384777

Group type: EXPERIMENTAL
Intervention: Ultrasound measurement of lower uterine segment thickness; those with measurements >3.5 mm encouraged to choose planned vaginal delivery, those with measurements ≤3.5 mm encouraged to choose planned repeat cesarean delivery.
Number of subjects: 2948

Group type: COMPARATOR
Intervention: Control group (standard management, no ultrasound measurement).
Number of subjects: 2948

Group type: EXPERIMENTAL
Intervention: Ultrasound measurement of lower uterine segment thickness.
Number of subjects: 2948

Group type: COMPARATOR
Intervention: Control group (standard management).
Number of subjects: 2948
Study: 32005226

Group type: EXPERIMENTAL
Intervention: Health education on TB to HH contacts by HEWs
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Having TB treatment supporter (TTS) during intensive phase of index TB case
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: HH visit by HEWs within 6 months prior to the programme assessment
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Discussions about TB activities by HEWs with Women Development Army (WDA) leaders
Number of subjects: 411
Study: 32117047

Group type: EXPERIMENTAL
Intervention: Behavioral-lifestyle intervention (PEARS) supported by a smartphone app
Number of subjects: 565

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 565
Study: 36215222

Group type: EXPERIMENTAL
Intervention: Cod liver oil (5 mL/day, 10 µg of vitamin D, n=17,278)
Number of subjects: 34601

Group type: COMPARATOR
Intervention: Placebo (n=17,323)
Number of subjects: 34601
Study: 34155732

Group type: EXPERIMENTAL
Intervention: Intramuscular active dose of morphine (0.15 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Very low dose control (0.01 mg/kg)
Number of subjects: 0
Study: 32878045

Group type: EXPERIMENTAL
Intervention: Refined deep-sea water (RDSW)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Mineral water (control)
Number of subjects: 98
Study: 35610013

Group type: EXPERIMENTAL
Intervention: Mianyi granules
Number of subjects: 361

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 361
Study: 33234053

Group type: EXPERIMENTAL
Intervention: Ending Self‐Stigma intervention
Number of subjects: 248

Group type: COMPARATOR
Intervention: Health and Wellness intervention
Number of subjects: 248
Study: 32211679

Group type: EXPERIMENTAL
Intervention: 6 g of mixed spices
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 2 g of mixed spices
Number of subjects: 13

Group type: COMPARATOR
Intervention: 0 g of mixed spices (no spices)
Number of subjects: 13
Study: 33586502

Group type: EXPERIMENTAL
Intervention: Cocaine-specific stimuli
Number of subjects: 80

Group type: COMPARATOR
Intervention: Neutral stimuli
Number of subjects: 80
Study: 35135928

Group type: EXPERIMENTAL
Intervention: SMA gait training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control gait training
Number of subjects: 15
Study: 33357089

Group type: EXPERIMENTAL
Intervention: Memory Training
Number of subjects: 80

Group type: COMPARATOR
Intervention: Health Education
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wait-List
Number of subjects: 80
Study: 36112258

Group type: EXPERIMENTAL
Intervention: Online visualization
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard PrEP briefing
Number of subjects: 146
Study: 34886058

Group type: EXPERIMENTAL
Intervention: Health education and DTC-GT (intervention group)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Health education (control group)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 144
Study: 35689178

Group type: EXPERIMENTAL
Intervention: Spirometry and lung age announcement along with usual care
Number of subjects: 456

Group type: COMPARATOR
Intervention: Standard program (control group)
Number of subjects: 456
Study: 33211387

Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (BVS) implantation
Number of subjects: 2070
Study: 35953437

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE)
Number of subjects: 8179
Study: 33530182

Group type: EXPERIMENTAL
Intervention: Intermittent cervical traction combined with traditional Chinese medicine hot compress
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intermittent cervical traction combined with hot compresses
Number of subjects: 100
Study: 35005585

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D supplementation (2800 IU/day) during pregnancy
Number of subjects: 584

Group type: COMPARATOR
Intervention: Vitamin D sufficiency (≥ 75 nmol/l) at age 6 months
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Vitamin D sufficiency at age 6 years
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D supplementation during pregnancy with vitamin D sufficiency at age 6 years
Number of subjects: 584
Study: 32293943

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive pill (OCP)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 33451738

Group type: EXPERIMENTAL
Intervention: rAAV2/2‐ND4 (single injection of 9 × 10^10 viral genomes in 90 μl)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 38
Study: 32228690

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 2026

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 2026